Evidence implicating peroxisome proliferator-activated receptor-? in the pathogenesis of preeclampsia

Medicine and Dentistry

• Pre-Eclampsia 100%
• Peroxisome Proliferator Activated Receptor 100%
• Protein Tyrosine Kinase 80%
• Trophoblast 60%
• Cell Proliferation 40%
• Placenta 40%
• Messenger RNA 20%
• Cell Differentiation 20%
• Transcription Factor 20%
• Perinatal Morbidity 20%
• Perinatal Mortality 20%
• Angiogenesis 20%
• Proteinuria 20%
• Thrombocyte Aggregation 20%
• Maternal Mortality 20%
• Peroxisome Proliferator Activated Receptor Antagonist 20%
• Endothelial Dysfunction 20%
• Mean Arterial Pressure 20%
• Vasculotropin 20%

Biochemistry, Genetics and Molecular Biology

• Peroxisome Proliferator-Activated Receptor 100%
• Soluble Fms-Like Tyrosine Kinase-1 60%
• Trophoblast 60%
• Blood Plasma 40%
• Cell Proliferation 40%
• Receptor Antagonist 20%
• Messenger RNA 20%
• Angiogenesis 20%
• Vascular Endothelial Growth Factor 20%
• Cellular Differentiation 20%
• Transcription Factor 20%
• Maternal Mortality 20%
• Perinatal Morbidity 20%
• Perinatal Mortality 20%
• Mean Arterial Pressure 20%
• Receptor Tyrosine Kinase 20%
• Thrombocyte Aggregation 20%
• Tyrosine Kinase 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Peroxisome Proliferator Activated Receptor 100%
• Preeclampsia 100%
• Protein Tyrosine Kinase 80%
• 2 Chloro 5 Nitro N (4 Pyridyl)benzamide 80%
• Messenger RNA 20%
• Vasculotropin 20%
• Transcription Factor 20%
• Maternal Mortality 20%
• Perinatal Morbidity 20%
• Perinatal Mortality 20%
• Endothelial Dysfunction 20%
• Proteinuria 20%
• Peroxisome Proliferator Activated Receptor Antagonist 20%